Ignite Creation Date:
2025-12-26 @ 11:08 AM
Ignite Modification Date:
2026-03-01 @ 12:16 AM
Study NCT ID:
NCT02977312
Status:
COMPLETED
Last Update Posted:
2016-11-30
First Post:
2016-11-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan
Sponsor:
Hikma Pharmaceuticals LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-08
Start Date Type:
None
Primary Completion Date:
2015-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-02
Completion Date Type:
ACTUAL
First Submit Date:
2016-11-22
First Submit QC Date:
None
Study First Post Date:
2016-11-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-29
Last Update Post Date:
2016-11-30
Last Update Post Date Type:
ESTIMATED